Skip to main content
Premium Trial:

Request an Annual Quote

TBG Biotechnology Wins Chinese Approval for HLA Typing Kits

NEW YORK (GenomeWeb) – Australian molecular diagnostics firm TBG Biotechnology announced today that it has received approval from the China Food and Drug Administration for its HLAssure SE SBT portfolio of high-resolution human leukocyte antigen (HLA) genotyping kits for hematopoietic cell transplantation (HCT).

According to the company, the newly approved kits cover HLA loci A, B, C, DRB1, and DQB1 — the primary genetic targets currently used for assessing the compatibility between hematopoietic cell donors and recipients. HCT is commonly used in the treatment of leukemia, lymphoma, aplastic anemia, and myelodysplastic syndromes.

TBG said that its Xiamen, China-based subsidiary is currently in discussions with hematopoietic cell transplantation laboratory distributors and service providers about rolling out the kits in that nation.

"China has one of the fastest growing allogeneic HCT markets with a [compound annual growth rate] of over 18.9 percent," Ifan Chiu, president of TBG's Xiamen unit, said in a statement. "We were determined to be the first to provide a CFDA-approved, high-resolution typing solution for the HLA typing laboratories in China."

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.